The MarketWatch News Department was not involved in the creation of this content. GERMANTOWN, MD AND CHICAGO, IL / ACCESS Newswire / December 16, 2025 / uBriGene Biosciences, a leading global ...
Lentiviral vectors are one of the foundational technologies of cell and gene therapy. Along with adenoviral vectors, they are one of the most widely used means of introducing genetic information into ...
Lentiviral vectors are derived from lentiviruses such as HIV-1 and serve as potent gene delivery vehicles due to their capacity to integrate stably into the host genome and transduce both dividing and ...
As lentiviral vector (LVV) programs advance toward larger clinical trials and commercialization, manufacturing platforms and analytical strategies must evolve together. In this joint webinar, Minaris ...
The field of cell and gene therapy is rapidly growing. In particular, the use of lentiviruses in CAR-T applications is becoming of higher importance. Lentiviruses are enveloped viruses that are rather ...
GERMANTOWN, MD / ACCESS Newswire / July 16, 2026 / uBriGene Biosciences, a global contract development and manufacturing organization (CDMO) specializing in cell and gene therapies, today announced th ...
Genezen, a cell and gene therapy CDMO specializing in lentiviral and retroviral vector manufacturing, completed construction of the early phase clinical cGMP manufacturing facility as a part of its ...
JUNCTION CITY, Kan., May 12, 2026 (GLOBE NEWSWIRE) -- InVitria, a global leader in chemically defined, animal-origin-free recombinant proteins for advanced therapy manufacturing, announced its ...
Acquired from the human immunodeficiency virus (HIV), lentiviral vectors are one of the most practical and commonly used viral vectors. They provide the ability to transduce both non-dividing and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results